Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study). Descourt R, Guisier F, Perol M, Cadranel J, et al. Lung Cancer (Auckl) 2025;16:107-114.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Descourt R, Guisier F, Perol M, Cadranel J, et al. Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study). Lung Cancer (Auckl) 2025;16:107-114.
PMID: 40821608